SPRIM PRO and ObvioHealth Strengthen Partnership for Advanced Clinical Trials with Digital Solutions

Advancements in Clinical Trials: SPRIM PRO and ObvioHealth Unite



In a groundbreaking development in clinical research, SPRIM PRO and ObvioHealth have announced an expansion of their collaboration, aimed at providing an integrated clinical trial solution that merges extensive scientific knowledge with cutting-edge digital technology. These sister companies, both part of the SPRIM Group, are set to redefine the standards for clinical trials by creating a more efficient, participant-friendly approach that leverages the strengths of both organizations.

A Strategic Alliance Empowering Clinical Trials


SPRIM PRO brings to the table over 24 years of experience in clinical operations, having successfully conducted more than 300 trials across 26 different therapeutic areas. With a strong foundation in protocol design and digital endpoint validation, they ensure that each clinical trial adheres to rigorous compliance standards. This expertise is complemented by ObvioHealth's innovative ObvioGo platform, designed to facilitate decentralized and hybrid trials through real-time data collection, mobile engagement, and streamlined digital workflows.

This strategic alliance not only aligns operational expertise and scientific rigor but also emphasizes the importance of participant engagement and retention. From the initial planning phases, the teams at SPRIM PRO and ObvioHealth work closely with trial sponsors to synchronize study design, chosen technologies, and engagement strategies, ultimately leading to faster startup times and improved trial outcomes.

Bridging Science with Technology


As clinical trials evolve, challenges surrounding participant engagement and data integrity have become more pronounced. This partnership addresses such challenges head-on. SPRIM PRO's extensive experience in developing validated endpoints ensures that all data captured is both sensitive and specific, while also effectively integrating wearables and telehealth functionalities through the ObvioGo platform. This seamless integration allows for a comprehensive view of participant data, fostering a better overall trial experience.

Susan Dallabrida, PhD, CEO of SPRIM PRO, expressed her enthusiasm for the collaboration, emphasizing a shared commitment to scientific integrity and operational excellence.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.